Safety of two-dose schedule of COVID-19 adsorbed inactivated vaccine (CoronaVac; Sinovac/Butantan) and heterologous additional doses of mRNA BNT162b2 (Pfizer/ BioNTech) in immunocompromised and immunocompetent individuals (2025)
- Authors:
- Autor USP: SARTORI, ANA MARLI CHRISTOVAM - FM
- Unidade: FM
- DOI: 10.1590/S1678-9946202567002
- Subjects: COVID-19; VACINAÇÃO; RNA MENSAGEIRO
- Language: Inglês
- Objetivos de Desenvolvimento Sustentável (ODS):
03. Saúde e bem-estar
- Imprenta:
- Source:
- Título: Revista do Instituto de Medicina Tropical de São Paulo
- ISSN: 0036-4665
- Volume/Número/Paginação/Ano: v. 67, article ID e2, 10p, 2025
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
MIYAJI, Karina Takesaki et al. Safety of two-dose schedule of COVID-19 adsorbed inactivated vaccine (CoronaVac; Sinovac/Butantan) and heterologous additional doses of mRNA BNT162b2 (Pfizer/ BioNTech) in immunocompromised and immunocompetent individuals. Revista do Instituto de Medicina Tropical de São Paulo, v. 67, 2025Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/82819. Acesso em: 22 jan. 2026. -
APA
Miyaji, K. T., Ibrahim, K. Y., Infante, V., Moreira, R. M., Santos, C. F. dos, Belizario, J. de C., et al. (2025). Safety of two-dose schedule of COVID-19 adsorbed inactivated vaccine (CoronaVac; Sinovac/Butantan) and heterologous additional doses of mRNA BNT162b2 (Pfizer/ BioNTech) in immunocompromised and immunocompetent individuals. Revista do Instituto de Medicina Tropical de São Paulo, 67. doi:10.1590/S1678-9946202567002 -
NLM
Miyaji KT, Ibrahim KY, Infante V, Moreira RM, Santos CF dos, Belizario J de C, Pinto MI de M, Marinho AKBB, Pereira JM, Sartori AMC. Safety of two-dose schedule of COVID-19 adsorbed inactivated vaccine (CoronaVac; Sinovac/Butantan) and heterologous additional doses of mRNA BNT162b2 (Pfizer/ BioNTech) in immunocompromised and immunocompetent individuals [Internet]. Revista do Instituto de Medicina Tropical de São Paulo. 2025 ; 67[citado 2026 jan. 22 ] Available from: https://observatorio.fm.usp.br/handle/OPI/82819 -
Vancouver
Miyaji KT, Ibrahim KY, Infante V, Moreira RM, Santos CF dos, Belizario J de C, Pinto MI de M, Marinho AKBB, Pereira JM, Sartori AMC. Safety of two-dose schedule of COVID-19 adsorbed inactivated vaccine (CoronaVac; Sinovac/Butantan) and heterologous additional doses of mRNA BNT162b2 (Pfizer/ BioNTech) in immunocompromised and immunocompetent individuals [Internet]. Revista do Instituto de Medicina Tropical de São Paulo. 2025 ; 67[citado 2026 jan. 22 ] Available from: https://observatorio.fm.usp.br/handle/OPI/82819 - Acompanhamento clínico e laboratorial de indivíduos com doença de Chagas e infecções pelo vírus da imunodeficiência humana
- Avaliação econômica da introdução de novas vacinas no Programa Nacional de Imunizações brasileiro
- Parasitemia por Trypanosoma cruzi em pacientes com doença de Chagas crônica co-infectados por vírus da imunodeficiência humana (HIV)
- Syphilis in pregnancy, congenital syphilis, and factors associated with mother-to-child transmission in Itapeva, Sao Paulo, 2010 to 2014
- Human Papillomavirus (HPV) seroprevalence, cervical HPV prevalence, genotype distribution and cytological lesions in solid organ transplant recipients and immunocompetent women in Sao Paulo, Brazil
- Network of Cold: fundamentals for the understanding of the work
- Raiva
- Adverse events following Quadrivalent HPV vaccination reported in Sao Paulo State, Brazil, in the first three years after introducing the vaccine for routine immunization (March 2014 to December 2016)
- Immunogenicity of COVID-19 adsorbed inactivated vaccine (CoronaVac) and additional doses of mRNA BNT162b2 vaccine in immunocompromised adults compared with immunocompetent persons
- School-based HPV vaccination program implementation in municipalities of the São Paulo State, Brazil, from 2015 to 2018
Informações sobre o DOI: 10.1590/S1678-9946202567002 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
